Figure 1.

Differences in coagulation biomarkers between the healthy control, metastasis, and nonmetastasis groups. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. APTT, activated partial thromboplastin time; AT, antithrombin; DD, d‐dimer; Fbg, fibrinogen; FDP, fibrin degradation product; HC, healthy control; INR, international normalized ratio; M, metastasis group; NM, nonmetastasis group; PIC, α2‐plasmininhibitor‐plasmin complex; PT, prothrombin time; TAT, thrombin‐antithrombin complex; TM, thrombomodulin; t‐PAIC, tissue plasminogen activator‐inhibitor complex; TT, thrombin time.